0
0
New Delhi, February 4, 2026 – On the eve of World Cancer Day, the Indian Cancer Society (ICS) warned that India faces a daunting rise in cancer cases, potentially increasing from 1.5 million new diagnoses annually to nearly 2.5 million by 2045, a 67% jump that underscores the urgent need for prevention and early screening programs.
Alarming Projections and Current Burden
India’s cancer incidence reached 1.46 million cases in 2022, with a crude rate of 100.4 per 100,000 people, making it the third-highest globally after China and the US. GLOBOCAN estimates project this to climb to 2.46 million by 2045, driven by aging populations, lifestyle shifts, and rising life expectancy. One in nine Indians now faces a lifetime cancer risk, with lung cancer leading in men and breast cancer in women.
These figures align with National Cancer Registry Programme (NCRP) data, showing female cases slightly outnumbering males at 749,251 versus 712,176 in 2022. Tobacco-related cancers, accounting for 35-50% of male cases, exacerbate the burden, particularly oral and lung types.
Expert Warnings and Calls to Action
At a media briefing by ICS Delhi, Jyotsna Govil, Chairperson, emphasized prevention over late-stage treatment: “The Budget opens the door for more affordable treatment, but our effort is to ensure patients do not reach advanced stages where these medicines become their only option.” Dr. Nitesh Rohatgi, Senior Director of Oncology at Fortis Memorial Hospital, added that “age-appropriate screening, early diagnosis and newer diagnostic tools can significantly improve outcomes and reduce the overall cost of care.”
Dr. Urvashi Prasad, a cancer survivor and former NITI Aayog director, highlighted systemic issues: regional disparities, weak data, and financial barriers delay diagnosis, calling for better Centre-state coordination. Dr. Monika Puri, former WHO official and public health consultant, advocated integrating screening into primary health systems for equitable access.
Independent oncologists echo this. Dr. Gopal Sharma noted, “In rural India, cancer is often found too late… limited access to screening services, low awareness, and financial constraints keep many from getting checked until it’s too late.” Early detection boosts survival: 76.3% for breast, 73.2% for cervical, and 60.2% for oral cancers when caught early, per Ministry of Health data.
Background and Risk Factors
India’s cancer rise mirrors global trends but is amplified by unique factors: tobacco use (57% of cases preventable), HPV/hepatitis infections, poor diet, obesity, pollution, and delayed healthcare access. ICMR studies project a 12.8% incidence hike by 2025 from 2020, with BRICS nations like India and South Africa hit hardest due to socioeconomic changes.
Urban-rural divides persist; northern and northeastern regions bear the highest Disability-Adjusted Life Years (DALYs), projected to rise from 26.7 million in 2021 to 29.8 million by 2025. Women face rising breast, cervical, and ovarian cancers, while men grapple with lung, mouth, and tongue types linked to tobacco.
Government Initiatives and Recent Budget Boost
The Union Budget 2026-27 introduced customs duty exemptions on select cancer drugs and promoted domestic biopharma manufacturing to cut costs. Under Ayushman Bharat and NPCDCS, population-based screening for breast, cervical, and oral cancers rolls out via National Health Mission, though coverage remains low in many districts.
ICS complements this with screening camps, the Rise Against Cancer app, Prashanti rehabilitation center, and financial aid for underprivileged patients. Yet experts caution that drug affordability alone won’t suffice without scaling primary-level screening.
| Cancer Type | Common in India | Key Risk Factors | Early Screening Method |
|---|---|---|---|
| Breast | Women (leading) | Age, genetics, obesity | Mammogram |
| Lung | Men (leading) | Smoking, pollution | Low-dose CT |
| Oral | Men | Tobacco, alcohol | Visual exam |
| Cervical | Women | HPV infection | Pap smear/HPV test |
Public Health Implications
This surge strains India’s healthcare: advanced-stage presentations inflate costs and mortality, with three in five diagnosed patients succumbing. Prevention could avert 30-50% of cases via tobacco control, HPV vaccination, healthy diets, and exercise. Early detection shifts outcomes—like mammograms reducing breast cancer mortality by 30%.
For readers, this means prioritizing screenings: women over 30 for cervical/breast checks, men for oral exams if tobacco users. Lifestyle tweaks—quitting tobacco, balanced diets—offer immediate impact. Equitable access could save millions in DALYs and economic loss.
Limitations and Counterarguments
Projections rely on models like GLOBOCAN, which may overestimate due to underreporting in rural areas or underestimate from improving controls. Screening programs face uptake challenges: only select districts implement effectively, hampered by awareness gaps and infrastructure. Critics argue overemphasis on screening diverts from pollution regulation or universal coverage, though experts counter it’s complementary.
Data inconsistencies across registries limit precision, per NCRP reviews. Success hinges on sustained funding amid competing health priorities.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
https://health.economictimes.indiatimes.com/news/industry/cancer-cases-in-india-may-rise-67-by-2045-experts-say-early-detection-crucial/127897221?utm_source=top_story&utm_medium=homepage
